{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T12:56:10Z","timestamp":1765284970891,"version":"3.46.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"11-12","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100014804","name":"Neurofibromatosis Therapeutic Acceleration Program","doi-asserted-by":"publisher","award":["212022"],"award-info":[{"award-number":["212022"]}],"id":[{"id":"10.13039\/100014804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum. Genet."],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00439-025-02786-2","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T06:58:22Z","timestamp":1760511502000},"page":"1199-1206","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The spectrum of pathogenic NF1 variants in participants enrolling on clinical trials of MEK inhibitors for plexiform neurofibroma"],"prefix":"10.1007","volume":"144","author":[{"given":"Chelsea","family":"Kotch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krista S.","family":"Schatz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Dombi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Symone","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea M.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e9lanie","family":"Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9bastien","family":"Perreault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyssa T.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Romo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Bornhorst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Tonsgard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian D.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Widemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"2786_CR1","doi-asserted-by":"publisher","unstructured":"Ahlawat S, Fayad LM, Khan MS, Bredella MA, Harris GJ, Evans DG, Farschtschi S, Jacobs MA, Chhabra A, Salamon JM, Wenzel R, Mautner VF, Dombi E, Cai W, Plotkin SR, Blakeley JO, Whole Body MRICftRIC, Members REIC (2016) Current whole-body MRI applications in the neurofibromatoses: NF1, NF2, and schwannomatosis. Neurology 87:S31\u20139. https:\/\/doi.org\/10.1212\/WNL.0000000000002929","DOI":"10.1212\/WNL.0000000000002929"},{"key":"2786_CR2","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1093\/neuonc\/noaa053","volume":"22","author":"S Akshintala","year":"2020","unstructured":"Akshintala S, Baldwin A, Liewehr DJ, Goodwin A, Blakeley JO, Gross AM, Steinberg SM, Dombi E, Widemann BC (2020) Longitudinal evaluation of peripheral nerve sheath tumors in neurofibromatosis type 1: growth analysis of plexiform neurofibromas and distinct nodular lesions. Neuro Oncol 22:1368\u20131378. https:\/\/doi.org\/10.1093\/neuonc\/noaa053","journal-title":"Neuro Oncol"},{"key":"2786_CR3","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.1212\/WNL.0000000000012436","volume":"97","author":"C Bettegowda","year":"2021","unstructured":"Bettegowda C, Upadhayaya M, Evans DG, Kim A, Mathios D, Hanemann CO, Collaboration REI (2021) Genotype-phenotype correlations in neurofibromatosis and their potential clinical use. Neurology 97:S91\u2013S98. https:\/\/doi.org\/10.1212\/WNL.0000000000012436","journal-title":"Neurology"},{"key":"2786_CR4","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1093\/neuonc\/noac165","volume":"24","author":"PMK de Blank","year":"2022","unstructured":"de Blank PMK, Gross AM, Akshintala S, Blakeley JO, Bollag G, Cannon A, Dombi E, Fangusaro J, Gelb BD, Hargrave D, Kim A, Klesse LJ, Loh M, Martin S, Moertel C, Packer R, Payne JM, Rauen KA, Rios JJ, Robison N, Schorry EK, Shannon K, Stevenson DA, Stieglitz E, Ullrich NJ, Walsh KS, Weiss BD, Wolters PL, Yohay K, Yohe ME, Widemann BC, Fisher MJ (2022) MEK inhibitors for neurofibromatosis type 1 manifestations: clinical evidence and consensus. Neuro Oncol 24:1845\u20131856. https:\/\/doi.org\/10.1093\/neuonc\/noac165","journal-title":"Neuro Oncol"},{"key":"2786_CR5","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/ajmg.a.33139","volume":"152A","author":"DG Evans","year":"2010","unstructured":"Evans DG, Howard E, Giblin C, Clancy T, Spencer H, Huson SM, Lalloo F (2010) Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A 152A:327\u2013\u200932. https:\/\/doi.org\/10.1002\/ajmg.a.33139","journal-title":"Am J Med Genet A"},{"key":"2786_CR6","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41431-021-01015-4","volume":"30","author":"C Forde","year":"2022","unstructured":"Forde C, Burkitt-Wright E, Turnpenny PD, Haan E, Ealing J, Mansour S, Holder M, Lahiri N, Dixit A, Procter A, Pacot L, Vidaud D, Capri Y, Gerard M, Dollfus H, Schaefer E, Quelin C, Sigaudy S, Busa T, Vera G, Damaj L, Messiaen L, Stevenson DA, Davies P, Palmer-Smith S, Callaway A, Wolkenstein P, Pasmant E, Upadhyaya M (2022) Natural history of NF1 c.2970_2972del p.(Met992del): confirmation of a low risk of complications in a longitudinal study. Eur J Hum Genet 30:291\u2013297. https:\/\/doi.org\/10.1038\/s41431-021-01015-4","journal-title":"Eur J Hum Genet"},{"key":"2786_CR7","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1002\/ajmg.a.63346","volume":"191","author":"A Goetsch Weisman","year":"2023","unstructured":"Goetsch Weisman A, Weiss McQuaid S, Radtke HB, Stoll J, Brown B, Gomes A (2023) Neurofibromatosis- and schwannomatosis-associated tumors: approaches to genetic testing and counseling considerations. Am J Med Genet A 191:2467\u20132481. https:\/\/doi.org\/10.1002\/ajmg.a.63346","journal-title":"Am J Med Genet A"},{"key":"2786_CR9","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1056\/NEJMoa1912735","volume":"382","author":"AM Gross","year":"2020","unstructured":"Gross AM, Wolters PL, Dombi E, Baldwin A, Whitcomb P, Fisher MJ, Weiss B, Kim A, Bornhorst M, Shah AC, Martin S, Roderick MC, Pichard DC, Carbonell A, Paul SM, Therrien J, Kapustina O, Heisey K, Clapp DW, Zhang C, Peer CJ, Figg WD, Smith M, Glod J, Blakeley JO, Steinberg SM, Venzon DJ, Doyle LA, Widemann BC (2020) Selumetinib in children with inoperable plexiform neurofibromas. N Engl J Med 382:1430\u20131442. https:\/\/doi.org\/10.1056\/NEJMoa1912735","journal-title":"N Engl J Med"},{"key":"2786_CR8","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1093\/neuonc\/noac109","volume":"24","author":"AM Gross","year":"2022","unstructured":"Gross AM, Glassberg B, Wolters PL, Dombi E, Baldwin A, Fisher MJ, Kim A, Bornhorst M, Weiss BD, Blakeley JO, Whitcomb P, Paul SM, Steinberg SM, Venzon DJ, Martin S, Carbonell A, Heisey K, Therrien J, Kapustina O, Dufek A, Derdak J, Smith MA, Widemann BC (2022) Selumetinib in children with neurofibromatosis type 1 and asymptomatic inoperable plexiform neurofibroma at risk for developing tumor-related morbidity. Neuro Oncol 24:1978\u20131988. https:\/\/doi.org\/10.1093\/neuonc\/noac109","journal-title":"Neuro Oncol"},{"key":"2786_CR11","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00439-017-1766-y","volume":"136","author":"H Kehrer-Sawatzki","year":"2017","unstructured":"Kehrer-Sawatzki H, Mautner VF, Cooper DN (2017) Emerging genotype-phenotype relationships in patients with large NF1 deletions. Hum Genet 136:349\u2013376. https:\/\/doi.org\/10.1007\/s00439-017-1766-y","journal-title":"Hum Genet"},{"key":"2786_CR10","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1007\/s00381-020-04717-0","volume":"36","author":"H Kehrer-Sawatzki","year":"2020","unstructured":"Kehrer-Sawatzki H, Kluwe L, Salamon J, Well L, Farschtschi S, Rosenbaum T, Mautner VF (2020) Clinical characterization of children and adolescents with NF1 microdeletions. Childs Nerv Syst 36:2297\u20132310. https:\/\/doi.org\/10.1007\/s00381-020-04717-0","journal-title":"Childs Nerv Syst"},{"key":"2786_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/s0165-4608(99)00006-0","volume":"113","author":"L Kluwe","year":"1999","unstructured":"Kluwe L, Friedrich RE, Mautner VF (1999) Allelic loss of the NF1 gene in NF1-associated plexiform neurofibromas. Cancer Genet Cytogenet 113:65\u201369. https:\/\/doi.org\/10.1016\/s0165-4608(99)00006-0","journal-title":"Cancer Genet Cytogenet"},{"key":"2786_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ajhg.2017.12.001","volume":"102","author":"M Koczkowska","year":"2018","unstructured":"Koczkowska M, Chen Y, Callens T, Gomes A, Sharp A, Johnson S, Hsiao MC, Chen Z, Balasubramanian M, Barnett CP, Becker TA, Ben-Shachar S, Bertola DR, Blakeley JO, Burkitt-Wright EMM, Callaway A, Crenshaw M, Cunha KS, Cunningham M, D\u2019Agostino MD, Dahan K, De Luca A, Destree A, Dhamija R, Eoli M, Evans DGR, Galvin-Parton P, George-Abraham JK, Gripp KW, Guevara-Campos J, Hanchard NA, Hernandez-Chico C, Immken L, Janssens S, Jones KJ, Keena BA, Kochhar A, Liebelt J, Martir-Negron A, Mahoney MJ, Maystadt I, McDougall C, McEntagart M, Mendelsohn N, Miller DT, Mortier G, Morton J, Pappas J, Plotkin SR, Pond D, Rosenbaum K, Rubin K, Russell L, Rutledge LS, Saletti V, Schonberg R, Schreiber A, Seidel M, Siqveland E, Stockton DW, Trevisson E, Ullrich NJ, Upadhyaya M, van Minkelen R, Verhelst H, Wallace MR, Yap YS, Zackai E, Zonana J, Zurcher V, Claes K, Martin Y, Korf BR, Legius E, Messiaen LM (2018) Genotype-phenotype correlation in NF1: evidence for a more severe phenotype associated with missense mutations affecting NF1 codons 844\u2013848. Am J Hum Genet 102:69\u201387. https:\/\/doi.org\/10.1016\/j.ajhg.2017.12.001","journal-title":"Am J Hum Genet"},{"key":"2786_CR14","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/s41436-018-0269-0","volume":"21","author":"M Koczkowska","year":"2019","unstructured":"Koczkowska M, Callens T, Gomes A, Sharp A, Chen Y, Hicks AD, Aylsworth AS, Azizi AA, Basel DG, Bellus G, Bird LM, Blazo MA, Burke LW, Cannon A, Collins F, DeFilippo C, Denayer E, Digilio MC, Dills SK, Dosa L, Greenwood RS, Griffis C, Gupta P, Hachen RK, Hernandez-Chico C, Janssens S, Jones KJ, Jordan JT, Kannu P, Korf BR, Lewis AM, Listernick RH, Lonardo F, Mahoney MJ, Ojeda MM, McDonald MT, McDougall C, Mendelsohn N, Miller DT, Mori M, Oostenbrink R, Perreault S, Pierpont ME, Piscopo C, Pond DA, Randolph LM, Rauen KA, Rednam S, Rutledge SL, Saletti V, Schaefer GB, Schorry EK, Scott DA, Shugar A, Siqveland E, Starr LJ, Syed A, Trapane PL, Ullrich NJ, Wakefield EG, Walsh LE, Wangler MF, Zackai E, Claes KBM, Wimmer K, van Minkelen R, De Luca A, Martin Y, Legius E, Messiaen LM (2019) Expanding the clinical phenotype of individuals with a 3-bp in-frame deletion of the NF1 gene (c.2970_2972del): an update of genotype-phenotype correlation. Genet Med 21:867\u2013876. https:\/\/doi.org\/10.1038\/s41436-018-0269-0","journal-title":"Genet Med"},{"key":"2786_CR13","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/humu.23929","volume":"41","author":"M Koczkowska","year":"2020","unstructured":"Koczkowska M, Callens T, Chen Y, Gomes A, Hicks AD, Sharp A, Johns E, Uhas KA, Armstrong L, Bosanko KA, Babovic-Vuksanovic D, Baker L, Basel DG, Bengala M, Bennett JT, Chambers C, Clarkson LK, Clementi M, Cortes FM, Cunningham M, D\u2019Agostino MD, Delatycki MB, Digilio MC, Dosa L, Esposito S, Fox S, Freckmann ML, Fauth C, Giugliano T, Giustini S, Goetsch A, Goldberg Y, Greenwood RS, Griffis C, Gripp KW, Gupta P, Haan E, Hachen RK, Haygarth TL, Hernandez-Chico C, Hodge K, Hopkin RJ, Hudgins L, Janssens S, Keller K, Kelly-Mancuso G, Kochhar A, Korf BR, Lewis AM, Liebelt J, Lichty A, Listernick RH, Lyons MJ, Maystadt I, Martinez Ojeda M, McDougall C, McGregor LK, Melis D, Mendelsohn N, Nowaczyk MJM, Ortenberg J, Panzer K, Pappas JG, Pierpont ME, Piluso G, Pinna V, Pivnick EK, Pond DA, Powell CM, Rogers C, Ruhrman Shahar N, Rutledge SL, Saletti V, Sandaradura SA, Santoro C, Schatz UA, Schreiber A, Scott DA, Sellars EA, Sheffer R, Siqveland E, Slopis JM, Smith R, Spalice A, Stockton DW, Streff H, Theos A, Tomlinson GE, Tran G, Trapane PL, Trevisson E, Ullrich NJ, Van den Ende J, Schrier Vergano SA, Wallace SE, Wangler MF, Weaver DD, Yohay KH, Zackai E, Zonana J et al (2020) Clinical spectrum of individuals with pathogenic NF1 missense variants affecting p.Met1149, p.Arg1276, and p.Lys1423: genotype-phenotype study in neurofibromatosis type 1. Hum Mutat 41:299\u2013315. https:\/\/doi.org\/10.1002\/humu.23929","journal-title":"Hum Mutat"},{"key":"2786_CR16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1159\/000529507","volume":"58","author":"C Kotch","year":"2023","unstructured":"Kotch C, Brosius SN, De Raedt T, Fisher MJ (2023) Updates in the management of central and peripheral nervous system tumors among patients with neurofibromatosis type 1 and neurofibromatosis type 2. Pediatr Neurosurg 58:267\u2013280. https:\/\/doi.org\/10.1159\/000529507","journal-title":"Pediatr Neurosurg"},{"key":"2786_CR17","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1038\/s41436-021-01170-5","volume":"23","author":"E Legius","year":"2021","unstructured":"Legius E, Messiaen L, Wolkenstein P, Pancza P, Avery RA, Berman Y, Blakeley J, Babovic-Vuksanovic D, Cunha KS, Ferner R, Fisher MJ, Friedman JM, Gutmann DH, Kehrer-Sawatzki H, Korf BR, Mautner VF, Peltonen S, Rauen KA, Riccardi V, Schorry E, Stemmer-Rachamimov A, Stevenson DA, Tadini G, Ullrich NJ, Viskochil D, Wimmer K, Yohay K, Huson C, Evans SM, Plotkin DG, International Consensus Group on Neurofibromatosis Diagnostic (2021) SR revised diagnostic criteria for neurofibromatosis type 1 and legius syndrome: an international consensus recommendation. Genet Med 23:1506\u20131513. https:\/\/doi.org\/10.1038\/s41436-021-01170-5","journal-title":"Genet Med"},{"key":"2786_CR18","doi-asserted-by":"publisher","first-page":"5678","DOI":"10.12998\/wjcc.v8.i22.5678","volume":"8","author":"MZ Li","year":"2020","unstructured":"Li MZ, Yuan L, Zhuo ZQ (2020) Gene diagnosis of infantile neurofibromatosis type I: a case report. World J Clin Cases 8:5678\u20135683. https:\/\/doi.org\/10.12998\/wjcc.v8.i22.5678","journal-title":"World J Clin Cases"},{"key":"2786_CR19","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1093\/hmg\/10.13.1387","volume":"10","author":"C L\u00f3pez-Correa","year":"2001","unstructured":"L\u00f3pez-Correa C, Dorschner M, Brems H, L\u00e1zaro C, Clementi M, Upadhyaya M, Dooijes D, Moog U, Kehrer-Sawatzki H, Rutkowski JL, Fryns J-P, Marynen P, Stephens K, Legius E (2001) Recombination hotspot in NF1 microdeletion patients. Hum Mol Genet 10:1387\u20131392. https:\/\/doi.org\/10.1093\/hmg\/10.13.1387","journal-title":"Hum Mol Genet"},{"key":"2786_CR20","doi-asserted-by":"publisher","first-page":"785982","DOI":"10.3389\/fped.2021.785982","volume":"9","author":"YT Lu","year":"2021","unstructured":"Lu YT, Zhang D, Liu XC, Zhang QY, Dong XQ, Fan P, Xiao Y, Zhou XL (2021) Identification of NF1 frameshift variants in two Chinese families with neurofibromatosis type 1 and early-onset hypertension. Front Pediatr 9:785982. https:\/\/doi.org\/10.3389\/fped.2021.785982","journal-title":"Front Pediatr"},{"key":"2786_CR21","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1200\/JCO.2024.42.16_suppl.3016","volume":"42","author":"CL Moertel","year":"2024","unstructured":"Moertel CL, Hirbe AC, Shuhaiber HH, Viskochil D, Sidhu A, Bielamowicz KJ, Weber M, Li J, Smith LM, Weintraub L, McNall-Knapp RY, Hajjar FM, Foreman NK, Gershon TR, Babovic-Vuksanovic D, Group ftRS (2024) ReNeu: a pivotal phase 2b trial of Mirdametinib in children and adults with neurofibromatosis type 1 (NF1)-associated symptomatic inoperable plexiform neurofibroma (PN). J Clin Oncol 42:3016\u20133016. https:\/\/doi.org\/10.1200\/JCO.2024.42.16_suppl.3016","journal-title":"J Clin Oncol"},{"key":"2786_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/genes13071130","author":"F Napolitano","year":"2022","unstructured":"Napolitano F, Dell\u2019Aquila M, Terracciano C, Franzese G, Gentile MT, Piluso G, Santoro C, Colavito D, Patane A, De Blasiis P, Sampaolo S, Paladino S, Melone MAB (2022) Genotype-phenotype correlations in neurofibromatosis type 1: identification of novel and recurrent NF1 gene variants and correlations with neurocognitive phenotype. Genes (Basel). https:\/\/doi.org\/10.3390\/genes13071130","journal-title":"Genes (Basel)"},{"key":"2786_CR23","doi-asserted-by":"publisher","first-page":"vdae177","DOI":"10.1093\/noajnl\/vdae177","volume":"6","author":"J Passos","year":"2024","unstructured":"Passos J, Soares MP, Salgado D, Nunes S, Cavaco D, Garrido PM, Coutinho M, Carvalho IP, Vilares M, Ferreira M, Lacerda C (2024) A single-center case study series assessing the effect of selumetinib use in patients with neurofibromatosis-related plexiform neurofibromas. Neurooncol Adv 6:vdae177. https:\/\/doi.org\/10.1093\/noajnl\/vdae177","journal-title":"Neurooncol Adv"},{"key":"2786_CR24","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.1038\/onc.2016.464","volume":"36","author":"A Pemov","year":"2017","unstructured":"Pemov A, Li H, Patidar R, Hansen NF, Sindiri S, Hartley SW, Wei JS, Elkahloun A, Chandrasekharappa SC, Program NCS, Boland JF, Bass S, Laboratory NDCGR, Mullikin JC, Khan J, Widemann BC, Wallace MR, Stewart DR (2017) The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromas. Oncogene 36:3168\u20133177. https:\/\/doi.org\/10.1038\/onc.2016.464","journal-title":"Oncogene"},{"key":"2786_CR25","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/jgc4.1303","volume":"29","author":"HB Radtke","year":"2020","unstructured":"Radtke HB, Bergner AL, Goetsch AL, McGowan C, Panzer K, Cannon A (2020) Genetic counseling for neurofibromatosis 1, neurofibromatosis 2, and Schwannomatosis-Practice resource of the National society of genetic counselors. J Genet Couns 29:692\u2013714. https:\/\/doi.org\/10.1002\/jgc4.1303","journal-title":"J Genet Couns"},{"key":"2786_CR26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/gcc.22997","volume":"61","author":"M Riva","year":"2022","unstructured":"Riva M, Martorana D, Uliana V, Caleffi E, Boschi E, Garavelli L, Ponti G, Sangiorgi L, Graziano C, Bigoni S, Rocchetti LM, Madeo S, Soli F, Grosso E, Carli D, Goldoni M, Pisani F, Percesepe A (2022) Recurrent NF1 gene variants and their genotype\/phenotype correlations in patients with neurofibromatosis type I. Genes Chromosomes Cancer 61:10\u201321. https:\/\/doi.org\/10.1002\/gcc.22997","journal-title":"Genes Chromosomes Cancer"},{"key":"2786_CR27","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1002\/humu.22832","volume":"36","author":"K Rojnueangnit","year":"2015","unstructured":"Rojnueangnit K, Xie J, Gomes A, Sharp A, Callens T, Chen Y, Liu Y, Cochran M, Abbott MA, Atkin J, Babovic-Vuksanovic D, Barnett CP, Crenshaw M, Bartholomew DW, Basel L, Bellus G, Ben-Shachar S, Bialer MG, Bick D, Blumberg B, Cortes F, David KL, Destree A, Duat-Rodriguez A, Earl D, Escobar L, Eswara M, Ezquieta B, Frayling IM, Frydman M, Gardner K, Gripp KW, Hernandez-Chico C, Heyrman K, Ibrahim J, Janssens S, Keena BA, Llano-Rivas I, Leppig K, McDonald M, Misra VK, Mulbury J, Narayanan V, Orenstein N, Galvin-Parton P, Pedro H, Pivnick EK, Powell CM, Randolph L, Raskin S, Rosell J, Rubin K, Seashore M, Schaaf CP, Scheuerle A, Schultz M, Schorry E, Schnur R, Siqveland E, Tkachuk A, Tonsgard J, Upadhyaya M, Verma IC, Wallace S, Williams C, Zackai E, Zonana J, Lazaro C, Claes K, Korf B, Martin Y, Legius E, Messiaen L (2015) High incidence of Noonan syndrome features including short stature and pulmonic stenosis in patients carrying NF1 missense mutations affecting p.Arg1809: genotype-phenotype correlation. Hum Mutat 36:1052\u20131063. https:\/\/doi.org\/10.1002\/humu.22832","journal-title":"Hum Mutat"},{"key":"2786_CR28","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.136262","author":"MM Tabata","year":"2020","unstructured":"Tabata MM, Li S, Knight P, Bakker A, Sarin KY (2020) Phenotypic heterogeneity of neurofibromatosis type 1 in a large international registry. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.136262","journal-title":"JCI Insight"},{"key":"2786_CR29","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1086\/510781","volume":"80","author":"M Upadhyaya","year":"2007","unstructured":"Upadhyaya M, Huson SM, Davies M, Thomas N, Chuzhanova N, Giovannini S, Evans DG, Howard E, Kerr B, Griffiths S, Consoli C, Side L, Adams D, Pierpont M, Hachen R, Barnicoat A, Li H, Wallace P, Van Biervliet JP, Stevenson D, Viskochil D, Baralle D, Haan E, Riccardi V, Turnpenny P, Lazaro C, Messiaen L (2007) An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970\u20132972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation. Am J Hum Genet 80:140\u2013151. https:\/\/doi.org\/10.1086\/510781","journal-title":"Am J Hum Genet"},{"key":"2786_CR30","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jmoldx.2010.09.002","volume":"13","author":"MC Valero","year":"2011","unstructured":"Valero MC, Martin Y, Hernandez-Imaz E, Marina Hernandez A, Melean G, Valero AM, Javier Rodriguez-Alvarez F, Telleria D, Hernandez-Chico C (2011) A highly sensitive genetic protocol to detect NF1 mutations. J Mol Diagn 13:113\u2013122. https:\/\/doi.org\/10.1016\/j.jmoldx.2010.09.002","journal-title":"J Mol Diagn"},{"key":"2786_CR31","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/(SICI)1096-8628(20000515)92:2<132::AID-AJMG10>3.0.CO;2-6","volume":"92","author":"DJ Waggoner","year":"2000","unstructured":"Waggoner DJ, Towbin J, Gottesman G, Gutmann DH (2000) Clinic-based study of plexiform neurofibromas in neurofibromatosis 1. Am J Med Genet 92:132\u2013135","journal-title":"Am J Med Genet"},{"key":"2786_CR32","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1200\/JCO.20.02220","volume":"39","author":"BD Weiss","year":"2021","unstructured":"Weiss BD, Wolters PL, Plotkin SR, Widemann BC, Tonsgard JH, Blakeley J, Allen JC, Schorry E, Korf B, Robison NJ, Goldman S, Vinks AA, Emoto C, Fukuda T, Robinson CT, Cutter G, Edwards L, Dombi E, Ratner N, Packer R, Fisher MJ (2021) NF106: A neurofibromatosis clinical trials consortium phase II trial of the MEK inhibitor Mirdametinib (PD-0325901) in adolescents and adults with NF1-Related plexiform neurofibromas. J Clin Oncol 39:797\u2013806. https:\/\/doi.org\/10.1200\/JCO.20.02220","journal-title":"J Clin Oncol"}],"container-title":["Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00439-025-02786-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00439-025-02786-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00439-025-02786-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T12:51:36Z","timestamp":1765284696000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00439-025-02786-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":32,"journal-issue":{"issue":"11-12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2786"],"URL":"https:\/\/doi.org\/10.1007\/s00439-025-02786-2","relation":{},"ISSN":["0340-6717","1432-1203"],"issn-type":[{"type":"print","value":"0340-6717"},{"type":"electronic","value":"1432-1203"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"25 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}